Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.

C H Weaver; J Potz; J Redmond; K Tauer; L S Schwartzberg; P Kaywin; R Drapkin; B Grant; P Unger; C Allen

doi:10.1038/sj.bmt.1700808

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.

NobleID: NI0P51W92R39S22
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/688CACD2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/688CACD2.svg?ark=w1%2F20260515%2F688CACD2&value=id)](https://nobleid.org/work/w1/20260515/688CACD2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.

NobleID: NI0P51W92R39S22
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/688CACD2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/688CACD2.svg?ark=w1%2F20260515%2F688CACD2&value=id)](https://nobleid.org/work/w1/20260515/688CACD2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work